PharmGen Science (004720.KS) Stock Price

PharmGen Science Price

CLOSED
2,850.00
​
Market closed

Revenue has compounded at 6.2% per year over the past 19 years to 173.07 B KRW. Earnings per share have declined at 5.7% per year over the last 18 years. PharmGen Science's net margin stands at -67.4%, down from 29.6% several years earlier.

PharmGen Science stock price

Access this data via the Eulerpool API

PharmGen Science business model & stock analysis

PharmGen Science, Inc. engages in the development and production of medicaments. The company is headquartered in Hwaseong, Gyeonggi-Do. The Company’s products include antiepileptic agents, anti-inflammatory agents, antiphlogistic agents, central nervous system agents, urinary agents, antihistamine agents, antivirus agents, agents for bones, agents for livers, calcium agents, antibiotics, diabetes agents, respiratory agents, as well as over-the-counter (OTC) drugs, obesity drugs, health food and others. In addition, the Company is also engaged in the manufacturing, wholesale and retail distribution of functional cosmetics. The firm distributes its products within domestic market and to overseas markets.

Frequently asked questions about PharmGen Science

Converted at the current exchange rate, the PharmGen Science share trades at 1.90 EUR (2,850.00 KRW).

The revenue cannot currently be calculated for PharmGen Science.

The profit cannot currently be calculated for PharmGen Science.

The P/E ratio cannot be calculated for PharmGen Science at the moment.

The P/S cannot be calculated for PharmGen Science currently.

The Eulerpool Quality Score for PharmGen Science is 2/10.

The ISIN of PharmGen Science is KR7004720009. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of PharmGen Science is 004720.KS. The ticker symbol is used to trade PharmGen Science shares on the stock exchange.

Fair ValueTerminal
2,907.00 KRW
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
South Korea
Currency
KRW
Initial public offering
Jun 15, 1990
ISIN
KR7004720009
Cusip
Y9T9HH108
Market capitalization
62.07 B KRWLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
10.37
P/B Ratio
0.42
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-79.73 %
Last updated Oct 9, 2026, 2:15 AM

PharmGen Science Peer Group

PharmGen Science FIGI

004720:KS · BBG000BGYGX2004720:KP · BBG000BGYH51